Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes
Status:
Completed
Trial end date:
2021-08-15
Target enrollment:
Participant gender:
Summary
To determine whether a heterologous vaccination regimen in individuals with no known previous
history of COVID-19 is non-inferior to that observed with counterpart regimens currently in
use in Argentina.
Phase:
Phase 2
Details
Lead Sponsor:
Ministerio de Salud de Ciudad Autónoma de Buenos Aires